David J Mauro

Title: David J Mauro: Innovator in Cancer Treatment

Introduction

David J Mauro is a notable inventor based in North Wales, PA (US), recognized for his contributions to cancer treatment through innovative therapies. With a total of 3 patents, Mauro has made significant strides in the field of oncology.

Latest Patents

Mauro's latest patents include a combination of a PD-1 antagonist and a VEGFR inhibitor for treating cancer. This patent describes combination therapies that utilize an antagonist of the Programmed Death 1 receptor (PD-1) alongside a VEGFR inhibitor, specifically targeting cancers that express PD-L1. Another significant patent involves a combination of a PD-1 antagonist and a listeria-based vaccine for treating prostate cancer. This therapy combines an antagonist of PD-1 with a strain that expresses prostate-tissue specific antigen (PSA), aimed at improving treatment outcomes for prostate cancer patients.

Career Highlights

Throughout his career, Mauro has worked with prominent companies in the pharmaceutical industry, including Pfizer Corporation and Merck Sharpe & Dohme Corp. His experience in these organizations has contributed to his expertise in developing innovative cancer therapies.

Collaborations

Mauro has collaborated with esteemed colleagues such as Rodolfo Fleury Perini and Jean-Francois Andre Martini, further enhancing his research and development efforts in the field of cancer treatment.

Conclusion

David J Mauro's work exemplifies the impact of innovation in the medical field, particularly in cancer treatment. His patents and collaborations reflect a commitment to advancing therapeutic options for patients.